Stocks and Investing
Stocks and Investing
Tue, November 10, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ATRA) at Strong Buy with Increased Target to $700 on, Nov 10th, 2020
Robert Burns of HC Wainwright & Co., Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Buy with Increased Target from $650 to $700 on, Nov 10th, 2020.
Robert has made no other calls on ATRA in the last 4 months.
There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Benjamin Burnett of "Stifel" Maintained at Strong Buy with Decreased Target to $700 on, Thursday, August 6th, 2020
Contributing Sources